alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[alpha-Neup5-Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-D-GlcpNAc-yl group

Term ID

CHEBI:132209

Synonyms

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-alpha-D-mannopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranon
alpha-Neu5Ac-(2-6)-beta-D-Gal-(1-4)-beta-D-GlcNAc-(1-2)-alpha-D-Man-(1-3)-[alpha-Neu5Ac-(2-6)-beta-D-Gal-(1-4)-beta-D-GlcNAc-(1-2)-alpha-D-Man-(1-6)]-beta-D-Man-(1-4)-beta-D-GlcNAc-(1-4)-[alpha-L-Fuc-(1-6)]-D-GlcNAc-yl
alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-D-GlcNAc-yl
N-acetyl-alpha-neuraminyl-(2-6)-beta-D-galactosyl-(1-4)-N-acetyl-beta-D-glucosaminyl-(1-2)-alpha-D-mannosyl-(1-3)-[N-acetyl-alpha-neuraminyl-(2-6)-beta-D-galactosyl-(1-4)-N-acetyl-beta-D-glucosaminyl-(1-2)-alpha-D-mannosyl-(1-6)]-beta-D-mannosyl-(1-4)-N-a
N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->6)]-beta-D-mannosyl-(
Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-3[Neu5Acalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-6]Manbeta1-4GlcNAcbeta1-4[Fucalpha1-6]GlcNAc-yl

Definition

A branched twelve-residue glucosaminyl group consisting of a linear sequence of D-mannosyl and two N-acetyl-D-glucosaminyl residues linked sequentially beta(1->4) and beta(1->4), to the N-acetyl-D-glucosaminyl residue at the reducing end of which is linked alpha(1->6) an L-fucosyl residue, while to the mannosyl residue are linked alpha(1->3) and alpha(1->6) two N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear tetrasaccharide unit and a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear trisaccharide units.

References

PMID:27114034

Ontology

ChEBI ( EBI )

Relationships

is a type of: glucosaminyl group

glucosaminyl group Show first 5 Terms

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[alpha-Neup5-Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-D-GlcpNAc-yl group

Phenotype where environments contain alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[alpha-Neup5-Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-D-GlcpNAc-yl group

Phenotype modified by environments containing alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[alpha-Neup5-Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-D-GlcpNAc-yl group

Human Disease Model